Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: Analysis of biological markers in a GEICAM phase II study

1. Estevez, L.G.
2. Fortes, J.L.
3. Adrover, E.
4. Peiró, G.
5. Margelí, M.
6. Castellá, E.
7. Cuevas, J.M.
8. Bernet, L.
9. Segui, M.A.
10. Andreu, X.